Trexquant Investment’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-16,924
Closed -$103K 1231
2019
Q2
$103K Sell
16,924
-150,965
-90% -$802K 0.01% 743
2019
Q1
$975K Buy
+167,889
New +$1.73M 0.07% 408
2018
Q4
Sell
-15,015
Closed -$291K 1436
2018
Q3
$291K Sell
15,015
-22,779
-60% -$485K 0.02% 694
2018
Q2
$966K Buy
+37,794
New +$881K 0.07% 385
2018
Q1
Sell
-16,661
Closed -$334K 1526
2017
Q4
$334K Buy
+16,661
New +$328K 0.04% 694
2017
Q3
Sell
-12,177
Closed -$180K 1143
2017
Q2
$180K Buy
+12,177
New +$203K 0.05% 688
2017
Q1
Sell
-37,238
Closed -$469K 1430
2016
Q4
$469K Buy
37,238
+24,729
+198% +$461K 0.07% 469
2016
Q3
$350K Buy
+12,509
New +$420K 0.08% 416
2016
Q1
Sell
-15,109
Closed -$517K 1280
2015
Q4
$517K Buy
+15,109
New +$471K 0.05% 667
2015
Q3
Sell
-6,300
Closed -$280K 1370
2015
Q2
$280K Buy
+6,300
New +$237K 0.03% 835

Other funds holding DPLO

Trexquant Investment's DPLO Position: Q3 2019 in Review

Trexquant Investment sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q3 2019, closing a stake of 16,924 shares — an estimated $103K sold.

Trexquant Investment first reported a position in DPLO in Q2 2015 and held it in 10 quarters. The position peaked at $975K in Q1 2019. 137 funds tracked by Wall St. Rank hold DPLO as of Q3 2019.

  • Trexquant Investment reported no remaining DIPLOMAT PHARMACY, INC. position as of Q3 2019 after selling out during the quarter.
  • Trexquant Investment sold 16,924 DIPLOMAT PHARMACY, INC. shares in Q3 2019, an estimated $103K.
  • Trexquant Investment first reported a position in DIPLOMAT PHARMACY, INC. in Q2 2015 and held it in 10 quarters.
  • Trexquant Investment's DIPLOMAT PHARMACY, INC. position peaked at $975K in Q1 2019.
  • 137 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q3 2019.

Based on Trexquant Investment's 13F filing for Q3 2019, filed 8 Nov 2019.